Phathom Pharmaceuticals, Inc. (PHAT)
12.55
-0.12
(-0.95%)
USD |
NASDAQ |
May 07, 09:42
Phathom Pharmaceuticals Free Cash Flow : -97.76M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Replimune Group, Inc. | -283.27M |
| ANI Pharmaceuticals, Inc. | 150.90M |
| MannKind Corp. | 13.69M |
| Ocugen, Inc. | -57.15M |
| Ligand Pharmaceuticals, Inc. | 38.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.65M |
| Cash from Investing (Quarterly) | -0.061M |
| Cash from Financing (Quarterly) | 66.64M |
| Free Cash Flow Per Share (Quarterly) | -0.1914 |
| Free Cash Flow to Equity (Quarterly) | 26.25M |
| Free Cash Flow to Firm (Quarterly) | 0.089M |
| Free Cash Flow Yield | -10.33% |